My Top Obesity Stock to Buy and Hold

Eli Lilly's Zepbound is already generating billions of dollars in revenue, making it the clear leader in a rapidly expanding market. Lilly's ability to produce and deliver creates a hurdle that smaller competitors can't easily overcome.